Dynamic positron emission tomography imaging of renal clearable gold nanoparticles
Optical imaging has been the primary imaging modality for nearly all of the renal clearable
nanoparticles since 2007. Due to the tissue depth penetration limitation, providing accurate …
nanoparticles since 2007. Due to the tissue depth penetration limitation, providing accurate …
PET imaging of VEGFR-2 expression in lung cancer with 64Cu-labeled ramucirumab
Lung cancer accounts for 17% of cancer-related deaths worldwide, and most patients
present with locally advanced or metastatic disease. Novel PET imaging agents for …
present with locally advanced or metastatic disease. Novel PET imaging agents for …
Near‐Infrared‐Emitting BODIPY‐trisDOTA111In as a Monomolecular Multifunctional Imaging Probe: From Synthesis to In Vivo Investigations
N Maindron, M Ipuy, C Bernhard… - … A European Journal, 2016 - Wiley Online Library
A new generation of monomolecular imaging probes (MOMIP) based on a distyryl‐BODIPY
(BODIPY= boron‐dipyrromethene) coupled with three DOTA macrocycles has been …
(BODIPY= boron‐dipyrromethene) coupled with three DOTA macrocycles has been …
Synthesis and evaluation of Cy5. 5-Rit tracer for specific near-infrared fluorescence imaging of sentinel lymph node
N Li, H Zhu, Y Li, J Wang, Z Yang - Bioorganic & Medicinal Chemistry …, 2016 - Elsevier
Sentinel lymph nodes biopsy (SLNB) is a critically important technique to determine the
metastatic status of primary breast cancer. Here we reported the new use of a conjugate …
metastatic status of primary breast cancer. Here we reported the new use of a conjugate …
[图书][B] Nanomaterials for Molecular Imaging: An Emerging Paradigm
S Shi - 2016 - search.proquest.com
Molecular imaging, the “visualization, characterization, and measurement of biological
processes at the molecular and cellular levels in humans and other living systems”, has …
processes at the molecular and cellular levels in humans and other living systems”, has …
RGD mimetics γ-AApeptides and methods of use (US 20,140,004,039 A1): a patent evaluation
The patent (US 20140004039 A1) claims Arg-Gly-Asp (RGD) mimetics based on a new type
of peptidomimetics–γ-AApeptides–which display high binding affinity and specificity to …
of peptidomimetics–γ-AApeptides–which display high binding affinity and specificity to …